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Abstract 
Klebsiella pneumoniae and Mycobacterium avium subspecies 
paratuberculosis (Map) are two important pathogens of cattle causing clinical 
mastitis (CM) and Johne‘s disease (JD), respectively. Information regarding the 
molecular diversity of these two pathogens is lacking from Newfoundland. The aim 
of this study was to evaluate the ability of different molecular techniques for bacterial 
species identification and strain discrimination, within and between dairy farms from 
Newfoundland. For CM, results demonstrate that molecular approaches were able to 
detect K. variicola and Enterobacter cloacae, which were misidentified as K. 
pneumoniae by standard biochemical/phenotypic tests. In the case of Map, fragment 
analysis of 4 short sequence repeats (SSRs) enhanced the capability to accurately 
differentiate between apparently identical isolates. Polyclonal infection patterns were 
observed for K. pneumoniae and Map in the current study. Therefore, the molecular 
identification of bacteria, along with precise genotyping analysis using contemporary 
and improved methods will be useful in future epidemiological studies. (149 words) 
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Chapter 1: General Introduction 
1.1 The importance of the dairy industry in Newfoundland  
The dairy industry, which includes dairy farms and dairy processing plants, is 
a major contributor to the economy. Dairy farms are involved in the production of 
raw milk, whereas dairy processing plants produce a variety of dairy products (such 
as processed milk, cheese, butter, yogurt, ice cream, etc.). Based on farm cash 
receipts, the dairy industry ranks third in the Canadian agriculture sector with 
Newfoundland and Labrador (NL) having the fewest number of dairy farms of all the 
provinces [1]. Although Quebec and Ontario are the major dairy producing provinces 
in Canada, NL has the highest number of dairy cows per individual farm and some of 
the largest farms in the country [1]. The close contact between large numbers of 
animals within dairy farms can make them prone to the spread of infectious diseases, 
which can cause substantial financial losses to the agricultural industry. Knowledge 
regarding the causative agents of these diseases can help implement better prevention 
and control programs, which can help to control and reduce disease occurrence. 
 
1.2 Bacterial pathogens associated with the dairy industry 
In addition to fungal, parasitic and viral agents, many diseases associated with 
bovine dairy animals are caused by bacterial pathogens from the genera 
Staphylococcus, Streptococcus, Escherichia, Corynebacterium, Klebsiella, 
Pseudomonas, Mycobacterium and Mycoplasma, to name a few [2-4]. Differences in 
herd management practices, environmental factors and host animal immune status can 
contribute to an increase in the occurrence of bacterial diseases [5]. Furthermore, 
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some diseases that infect dairy animals are zoonotic in nature and can therefore be 
transmitted to humans [6], highlighting the importance of understanding them better. 
The work described in this thesis will focus on two bacterial pathogens affecting 
dairy animals: (i) Klebsiella species, one of the causative agents of environmental 
clinical mastitis (CM, cases where the cow displays definitive symptoms of 
inflammation of the mammary glands and udder tissue) and (ii) Mycobacterium 
avium subspecies paratuberculosis (Map), which causes Johne‘s disease (JD), a 
contagious bacterial disease of the intestine which is associated with inflammation.  
 
1.3 Mastitis and Klebsiella species 
Mastitis in dairy animals is caused by a number of microorganisms, with the 
major ones being Streptococcus uberis, Staphylococcus aureus and E. coli [7]. Other 
pathogens include Streptococcus agalactiae, Streptococcus dysgalactiae, 
Corynebacterium bovis, Mycoplasma spp.,other Staphylococcus spp., Klebsiella spp., 
Citrobactor spp., Enterobacter spp., Pseudomonas aeruginosa, Pasteurella spp. and 
Bacillus spp. [7]. Sometimes fungi, yeasts and molds are also present in the infected 
tissues [7]. Major and minor pathogens can be distinguished by the difference in 
somatic cell counts (SCCs, such as white blood cells) and clinical signs such as 
reduced milk production and occasionally by animal mortality [5]. It has been 
reported that reduction in milk production depends on the specific pathogen causing 
CM, and that Gram negative bacteria are responsible for greater losses than Gram 
positive bacteria and other microorganisms [8,9]. Presently, K. pneumoniae is 
emerging as a pathogen of concern associated with veterinary and human medicine 
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due to its ability to acquire and disseminate antibiotic resistance capabilities [10,11]. 
In a previous study, CM caused by Klebsiella spp. was responsible for significant 
reduction in milk yields in multiparous animals (animals having experienced more 
than one parturition) [12]. Therefore, precise knowledge of the infectious agent is 
important for making decisions regarding treatment and control of the disease.  
Mastitis-causing pathogens can spread either from one animal to another 
(classified as contagious pathogens), or can be acquired from the environment 
(classified as environmental pathogens, which includes K. pneumoniae) such as 
animal bedding, manure and soil [13,14]. Contagious pathogens are usually present 
on the udder and teats, and are transferred from infected to uninfected animals during 
milking by the equipment or the handler. Environmental pathogens differ from 
contagious pathogens as they do not normally adhere to the udder or the teats [7]. 
Animals infected with environmental pathogens usually have lower SCCs as 
compared to those infected by contagious pathogens [15]. 
Klebsiella are rod-shaped Gram negative facultative anaerobes [16]. K. 
pneumoniae and K. oxytoca are closely related opportunistic pathogens [7] which are 
usually shed in the feces and milk of infected cows [10,17]. Generally cows with 
mastitis (especially Klebsiella associated mastitis) do not regain their full milk 
production levels post recovery, which leads to considerable economic losses [18]. 
Animals with Klebsiella associated mastitis are more likely to undergo mortality or to 
be culled as compared to animals with other types of mastitis [14,16,19]. Vaccination 
decreases the severity and occurrence of the clinical cases of coliform mastitis, but it 
cannot reduce the total number of new CM cases caused by Klebsiella spp. [14,20]. 
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Therefore, it is important to know the source of the mastitis infection (as it can infect 
both lactating and dry cows) for effective prevention or control programs.  
 
1.3.1 K. pneumoniae transmission and diagnosis 
In the majority of cases, signs of CM include abnormal milk (flakes, clots and 
watery milk) and udder swelling [7]. Animals can also have a fever and display other 
symptoms which include lack of appetite, sunken eyes, diarrhea, dehydration and 
reduction in mobility [7]. There are also subclinical cases where the milk appears 
normal and animals have no clinical signs of mastitis. These subclinical cases can be 
a source of infection where transmission happens largely through fecal shedding [21]. 
CM is usually diagnosed through cultures of milk samples [10] as fecal shedding is 
not associated with active/clinical infections [14]. Major outbreaks of CM have been 
reported from numerous countries, mostly within the initial two weeks of lactation in 
animals [22]. These infections were linked to environmentally contaminated wood 
shavings or sawdust used in bedding and stalls [14]. In the environment, K. 
pneumoniae can survive as an endophyte (an organism that lives within a plant 
without causing any apparent disease) of wheat, corn and alfalfa, and aids in nitrogen 
fixation. Consequently, plant parts that are consumed by animals can be a source of 
infection even in the absence of contaminating animal feces [14]. Therefore, K. 
pneumoniae can be acquired by animals through crops used for feed, or by fecal 
contamination of the environment.  
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1.3.2 Economic impact of CM 
Worldwide economic losses due to mastitis are immense, though actual losses 
vary from country to country [23]. The presence of animals with CM on Canadian 
dairy farms, especially lactating animals, is of major concern to the dairy industry. 
The deteriorating physical condition of infected animals and the decrease in milk 
quality and production levels cause significant economic losses to farmers and the 
dairy industry [7]. Other factors influencing financial losses are medication expenses, 
removal of contaminated bulk milk, culling and replacement of infected cattle and 
penalties for not meeting milk quality standards [7,24,25]. This has a huge impact not 
only on the dairy farmers, but also on consumers [23].  
In Canada, S. aureus is the main cause of contagious CM, whereas Klebsiella 
associated environmental CM is not as prevalent [26]. However, when compared to 
other Gram negative pathogens such as E coli, mastitis caused by Klebsiella spp. is 
responsible for greater losses due to reduced milk production and longer periods of 
infection [16]. According to a previous report on Canadian dairy farms, CM caused 
by Klebsiella spp. occurs more frequently in animals housed in free stalls as 
compared to those housed in tie-stalls (animal tied in by a neck-chain) [27]. 
Therefore, farm practices can play an important role in the prevalence of diseases 
caused by particular pathogens, highlighting the importance of identifying an agent 
and its source. 
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1.3.3 Pathogenesis and pathology 
Diverse groups of bacteria can cause CM, which include different or multiple 
isolates within the same species. The teat canals of dairy animals have physical and 
chemical barriers that inhibit the entrance of pathogens, but become vulnerable during 
calving and lactation [7,28]. During this period, CM causing pathogens release toxins 
that are recognized by the host immune system, which in response recruit more 
specialized immune cells to the site of the infection to combat the invading bacteria, 
causing inflammation and reduced milk production [7,28]. This leads to the 
manifestation of noticeable signs characteristic of CM, such as the reddening of the 
udder and the production of milk with watery appearance, which sometimes contains 
clots and flakes [7,28]. In subclinical mastitis, there are no visible changes in the milk 
or the udder, despite having inflammation in the mammary glands, and in cases of 
chronic mastitis, inflammation progression can continue for months and may persist 
from one lactation period to another [7]. 
 
1.3.4 Diagnostic and molecular tools for research on Klebsiella spp. associated 
with CM 
To reduce the cost of mastitis treatment, early and accurate detection of the 
pathogen is very important. Assays used for CM diagnosis and pathogen 
identification include measurement of SCCs in milk, immunoassays, multiplex 
polymerase chain reaction (PCR), quantitative PCR, culture based tests, mass 
spectroscopy based identification of the pathogen, electrical conductivity tests and 
infra-red thermography of milk [7,28], most of which are expensive and labour 
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intensive. Currently, culture based techniques, along with biochemical tests, are 
considered the gold standard methods to detect mastitis-causing pathogens, but the 
search for more robust methods continues. 
Although molecular detection techniques are more complex and cumbersome 
than culture based methods due to the involved equipment, protocols and reagents, in 
many instances they provide faster and more accurate results.  Numerous nucleic acid 
sequence based testing methods such as multiplex PCR and quantitative PCR have 
been developed for the detection of mastitis pathogens in milk [7,29], which are more 
sensitive and faster than other diagnostic/molecular tools. Moreover, quantitative 
multiplex PCR can detect up to 11 bovine mastitis pathogens within a few hours [30]. 
In addition, sequencing of the 16S rRNA, rpoB (beta subunit of RNA polymerase) 
and other genes is commonly used to identify/type bacteria, mainly for research 
purposes [19,31,32]. Nucleic acid sequence based amplification assays are being 
perfected using information available from the whole genome sequences of 
pathogenic bacteria, as they have the capability to distinguish between dead, spore-
forming, dormant and actively growing microorganisms in milk in a short period 
[28,33].  
Despite the prevalence of Klebsiella mastitis (CM caused by Klebsiella spp. 
only) in dairy cattle [19], information regarding the transmission and molecular 
diversity of the pathogen is still insufficient for successful control programs [34]. 
Molecular typing methods can differentiate strains and are able to track the 
transmission of isolates between and within farms. Genotyping techniques for 
Klebsiella spp. include pulsed-field gel electrophoresis (PFGE), random amplified 
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polymorphic DNA (RAPD) analysis, repetitive DNA sequence PCR, ribotyping, 
multilocus sequence typing (MLST), gyrA (DNA gyrase subunit A) and parC 
(subunit of topoisomerase IV) gene sequencing and amplified fragment length 
polymorphism (AFLP) analysis [31,32,35,36]. These methods can enhance the 
discriminatory power for molecular typing analysis to provide deeper insight into 
strain prevalence and relatedness. 
 
1.3.5 Drugs used for the treatment of CM 
At present, the following 11 drugs are used for treating CM caused by Gram 
negative and Gram positive bacteria: oxytetracycline, trimethoprim-sulphadoxine, 
ceftiofur, cephapirin, erythromycin, pirlimycin, procaine, penicillin G, streptomycin, 
novobiocin, polymyxin B and cortisone [37]. Tetracycline (41%), cephalosporin 
(78%) and most importantly penicillin (86%) are the most frequently used antibiotics 
for CM treatment in dairy farms [7]. Trimethoprim sulfa or tetracycline is widely 
used for treating calves, whereas ceftiofur (80%), tetracycline (31%) and penicillin 
(32%) are used for adult cows [7,38]. In addition, cephalothin, ceftiofur, pirlimycin, 
novobiocin, streptomycin, tetracycline, trimethoprim sulfamethoxazole or TMP-sulfa 
are used for the treatment of CM cases in Newfoundland (Table 1.3.5.1) (Animal 
Health Laboratory, Animal Health Division, Department of Natural Resources, 
Newfoundland and Labrador, Canada).   
Treatment of CM caused by Klebsiella spp. has a lower rate of success when 
compared to infections caused by Gram positive pathogens [16]. Schukken et al. 
(2011) reported that a third generation cephalosporin (ceftiofur hydrochloride) was 
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successful in treating uncomplicated cases of Klebsiella associated CM in dairy 
animals [38]. However, the majority of studies regarding antibiotic treatment 
outcomes on Klebsiella mastitis demonstrated the inadequate effectiveness of 
standard drug regimens [16]. Therefore, it is important to ensure that antibiotic 
resistance does not arise for any agents showing even low to moderate levels of 
efficacy; otherwise even the slightest hopes of treatment possibilities would be lost. 
 
1.4 Map and JD 
Map is the etiological agent of JD, which is associated with chronic 
inflammation of the small intestine of cattle, sheep, goats, farmed deer and other 
ruminants [39-44]. Map is an acid-fast, intracellular pathogenic bacterium [45], and 
requires specific conditions for replication in vitro. However, Map can survive in a 
dormant or non-replicating state under unfavorable conditions as well, which creates 
severe problems for eradicating Map from herds with JD [46]. JD shares some 
clinical and pathological features with human Crohn‘s disease (CD), making JD a 
cause for public concern [47]. In addition, Map has also been isolated from some, but 
not all patients with CD [48,49], HIV-AIDS [50-53] and type 1 diabetics [54], 
causing some concern regarding its association with humans having abnormal 
immune systems. Therefore, JD has become a major topic of discussion within the 
agricultural industry due to the potential link between Map and public health [43]. 
JD causes reduced milk production in dairy animals, and severe cases can lead 
to premature culling [55]. Owing to the economic impact of Map on the dairy 
industry, it has been studied extensively [56-58]. In Canada, the assessed yearly 
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losses caused by JD are CDN$ 15 million nationwide, and CDN$ 0.84 million for 
Canadian Maritime Provinces [59]. However, actual losses can be underestimated due 
to the lack of proper identification/diagnosis of infected animals and the absence of 
clinical symptoms in many infected animals [59]. In addition, there is no report 
regarding economic losses caused due to JD in NL to date.  
 
1.4.1 Map transmission 
Map transmission can occur through contaminated soil (such as pastures), 
contaminated water and infected animal feces. Map can survive for more than two 
years in the soil due to dormancy, which is responsible for bacterial survival under 
unfavorable conditions until the bacteria is taken up by a susceptible host [46]. The 
main animal to animal transmission pathways for Map are the fecal-oral route [60], 
consumption of infected milk by calves [61], transmission during birth and/or 
exposure to an infected animal [60,62]. Some epidemiological studies suggested that 
transmission of Map occurs early in a calf‘s life [60]. Young calves are more 
susceptible to infections than the adults, as adults require a substantial amount of 
bacterial load in order to become infected [43,61]. Calf management has been 
proposed for farm level Map eradication [63], but this was shown to be unsuccessful 
due to the other routes of transmission. Bioaerosols have also been suggested as a 
transmission route [64], as dust containing Map can be ingested and inhaled by 
animals leading to infection and spread of the disease [62,65]. Map spreads between 
and across species with no constraints, making it difficult to control. Moreover, wild 
animals can act as reservoirs and may transfer the bacteria to and between farms [66]. 
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Waterborne Map is also known to be a source of infection and there are some reports 
where large quantities of Map were washed into the rivers from farm lands in the 
Midwest United States, which then reached some provinces of Canada (Manitoba, 
Saskatchewan and Alberta) [67]. Therefore, it is important to investigate the source of 
Map and its transmission in order to devise effective control programs. 
 
1.4.2 Cell structure and metabolism 
Mycobacterial species usually produce a secreted lipophilic siderophore called 
mycobactin, which is involved in the binding of extracellular iron for transport into 
the cell [68]. Iron is an essential nutrient for growth, and Map is unique amongst the 
mycobacteria because it is not capable of producing mycobactin [69,70]. In vivo, 
infected host macrophages usually provide the iron necessary for Map growth and 
replication, but mycobactin is essential for culturing Map under in vitro conditions   
[71]. However, the requirement for mycobactin can differ based on the media used 
for culture purposes. In a previous study, isolates collected from clinical cases of 
sheep paratuberculosis required mycobactin for growth on a Lowenstein-Jensen (LJ) 
medium, but the same Map isolates did not require mycobactin when cultured on 
Middlebrook 7H11 agar [72]. The reason for the differences in mycobactin 
requirement might be due to strain variation or specific components present in the 
different media [71,73]. Map is also unable to use iron and multiply in soil or water 
environments [46,61]. 
 Similar to other mycobacteria, the cell wall of Map has a highly impermeable 
lipid rich barrier comprised of mycolic acids, which enables it to survive extreme 
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environmental conditions [74]. In addition, the cell wall enables Map to escape from 
host defenses and to survive within the phagosome of the host cell for up to two 
weeks [45]. In bovine macrophages, Map cell wall components modulate host 
responses for bacterial survival, such as intracellular multiplication and initiation of 
pathogenesis [45,75]. Up to 60% of the Map cell wall is comprised of complex lipids, 
due to which it exhibits the following properties: acid-fastness, increased 
lipophilicity, and resistance to a number of adverse conditions/reagents (low pH, 
ultraviolet light, high temperature, pasteurization, certain chemicals, hydrophilic 
antibiotics, etc.) [61,75]. The growth rate of Map is one of the slowest of all 
mycobacteria, which is partly attributed to the thick hydrophobic cell wall that acts as 
a barrier for the flow of nutrients [74]. The cell wall characteristics of Map along with 
its metabolism are important factors in diagnosis and for cultivating the bacterium. 
 
1.4.3 Pathogenesis and pathology 
Macrophages have the capability to kill a wide range of bacterial pathogens. 
Map can avoid this killing activity, and can grow and replicate inside macrophages 
[61]. This phenomenon is not only due to the chemically distinct cell wall of Map, but 
is also attributed to effector molecules secreted by the pathogen that neutralize the 
antibacterial chemicals produced by macrophages, thereby suppressing immune 
reactions [76,77]. Therefore, pathology and host cell dysfunction due to Map occurs 
because of the direct action of bacterial products combined with the host‘s immune 
response to the pathogen.  
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JD development can be divided into four stages: silent infection, subclinical, 
clinical and advanced clinical disease [55]. Following ingestion, Map initially 
establishes itself in the lymphoid tissue of the gastrointestinal tract of the animal 
(silent infection) [45]. Clinical signs and symptoms of the disease will not be 
noticeable during the initial years following infection, which can take up to ten years 
[47]. During this time, some of the Map cells are engulfed by macrophages, which 
initiate immune reactions such as lymphocyte instigation and clonal proliferation 
(subclinical stage). In subclinical cases, infected cows shed Map without exhibiting 
any clinical signs of the disease [43,57]. In addition, certain animals may never 
display any clinical signs of JD due to the host‘s immune system, such that they 
remain undetected and continue to infect other animals in the same herd [55,78]. 
After the initial immune response, infected animals start to display signs of the 
disease (clinical stage) [55], which include diarrhea, weight loss, decline in milk 
production and fatigue [3,43,79]. During this period the intestinal wall thickens due to 
inflammation, and after some time intestinal cells stop functioning, leading to 
malabsorption and enteropathy (advanced clinical stage) [61]. The pathology of JD 
can provide information about the infected animal‘s disease history and status, which 
when combined with analysis of Map isolates can provide a clearer picture on the 
molecular epidemiology of the disease. 
 
1.4.4 Diagnosis 
As for any infectious disease, prompt and proper diagnosis is necessary for the 
early detection and treatment of infected animals to prevent culling, along with the 
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spread of JD. Diagnosis has been proven to be more successful when an entire herd is 
examined rather than screening only suspected infected animals [43]. Unfortunately, 
tests for inspecting an entire herd are costly, laborious and time consuming [47,80], 
and vaccination can only reduce the rate of disease spread and not prevent JD 
occurrence [61,67]. There are a number of test methods available for diagnosing JD, 
such as: histopathology, microscopy, culture, PCR, agar gel immune-diffusion, 
enzyme-linked immunosorbent assay (ELISA), complement fixation test, delayed-
type hypersensitivity and gamma interferon release assay [59,81-87].  
Microscopy can be performed on fecal matter, fecal culture, and intestinal 
mucosal smears after Ziehl-Neelsen staining [88]. However, microscopy cannot 
distinguish Map from other mycobacterial species since all of them have acid-fast 
properties. In addition, specific sample smears on a slide might not contain Map at 
detectable levels. So, microscopy is not useful for confirmation of a negative case 
based upon a single fecal sample. 
Cultivation of Map from a live animal specimen is considered ‗the gold 
standard‘ for diagnosis [88, 89]. Although Map requires a long time to grow in 
culture media and is prone to contamination, culture results provide 100% specificity 
and are regarded as the ‗definitive diagnosis of infection‘ [88]. The true infection 
status of an individual animal can be determined through culturing multiple (up to 
100 sites) samples of intestinal tissue [90]. Fecal culture is the best non-invasive and 
most inexpensive diagnostic method for JD, but the rate of detecting Map in feces 
from infected animals is not consistent [84]. When successful, fecal culture can detect 
all the four stages of disease progression in an infected animal [88].  
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Since fecal samples contain many microorganisms in addition to Map, they 
require special treatments to enrich Map and to prevent the growth of contaminating 
microorganisms during subsequent culturing. There are two main methods for sample 
decontamination before Map culture: the first method uses oxalic acid combined with 
sodium hydroxide, and the second method uses hexadecylpyridinium chloride [88]. 
Increasing treatment times during the decontamination process can prevent the 
growth of unwanted bacteria and fungi, but it may also interfere with the subsequent 
growth of Map [91,92].  
Previous studies have suggested that certain media might be better suited for 
cultivating and isolating colonies of Map. Various types of liquid, egg-based, and 
agar-based culture media have been used for Map cultivation, some of which include: 
Herrold‘s egg yolk medium, LJ medium, Middlebrook 7H9 broth, Middlebrook 7H10 
agar, Middlebrook 7H11 agar, liquid BACTEC
TM
 12B or Middlebrook 7H12 
supplemented with egg yolk, Trek-ESP II liquid culture, Kirchner liquid medium, 
Dubos Broth-base medium, Sauton‘s liquid medium, and the Proskauer and Beck 
liquid medium [53,71,90,93,94]. On solid media, small colonies of Map become 
visible after two to six months and liquid cultures show growth within 3-6 weeks, 
when incubated at the optimal temperature (37°C) and under aerobic conditions 
[3,75,88], although the time required for the appearance of isolated colonies varies 
according to media and the specific isolate [71]. As mentioned previously, Map 
generally requires exogenous mycobactin such as mycobactin J for growth in culture 
medium. However, Map sub-cultures can grow in a medium that has no mycobactin 
added because of iron carry-over from the primary culture [71,88]. For selective 
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growth of mycobacteria, media supplements, such as oleic acid, albumin, dextrose 
and catalase (OADC or ADC) are added to the medium, along with glycerol. 
Contamination can be reduced by adding antimicrobial agents, such as polymyxin B, 
amphotericin B, carbenicillin, trimethoprim lactate, nalidixic acid and azlocillin, to 
the media [53]. The addition of detergents such as Tween 80 helps to prevent the 
clumping of Map cells in liquid cultures so that dispersed growth can be attained [53]. 
Liquid supplements, such as sodium pyruvate that can function as a source of energy 
and protects against toxic hydrogen peroxide, can have beneficial effects, but they can 
also inhibit the growth of some Map strains [71,95]. Therefore, the proper selection of 
growth media and supplements is crucial for successful Map cultivation in the 
laboratory. 
 
1.4.5 Molecular tools used for diagnosis and research 
IS900, an insertion sequence (transposable DNA fragment) specific for Map, 
is used as the target for PCR amplification to identify Map in milk and fecal samples 
from infected animals [88,96]. Additional insertion sequences which are specific for 
Map include: IS1311, ISMav2, f57 and ISMap02 [88,97,98]. However, IS900 is 
commonly used as it can be easily detected due to the presence of 17 copies of the 
sequence per Map cell [99]. PCR provides more rapid results when compared to most 
other diagnostic assays, but it has lower sensitivity as compared to fecal culture due 
to the presence of PCR inhibitors and low template DNA yields from samples 
[55,100,101]. Therefore, IS900 PCR is commonly used for Map detection and 
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identification in Canada in combination with culture [55]. Quantitative PCR has also 
been reported to perform well for detecting Map from environmental sources [102]. 
The selection of appropriate sample collection, processing and DNA 
extraction procedures are important factors when conducting PCR on samples from 
animals infected with Map [102]. There are a number of methods for extracting high 
quality DNA from Map to conduct PCR, which include rapid lysis, organic 
extraction, silica particle-based and magnetic particle-based technologies [101]. The 
particle-based technologies give better yields and higher quality Map DNA in a short 
period of time for PCR analysis [101]. In addition, homogenization of samples by 
bead-beating prior to DNA extraction improved PCR performance [43], a factor that 
will be considered while performing the analysis described in chapter three of this 
thesis. 
 
1.4.6 Epidemiological aspects of Map 
Studying the epidemiology of JD is extremely important due to the financial 
losses caused by the disease [49,101,103] and the probable association between Map 
and CD in humans [3,104,105]. In a number of studies, viable Map was detected in 
certain dairy products such as pasteurized milk and cheese [106,107], which could 
have implications on the health of consumers [49,108]. Molecular techniques have 
been developed and applied to understand the transmission of Map and for identifying 
predominant strains [3,99]. In many dairy herds, distinct strains of Map were found to 
cause JD in different animals [3], but there are also reports where single or related 
strains were responsible for infections [43]. Therefore, to implement successful 
 18 
 
control programs, it is necessary to find the source of the strain(s) in question. It is 
important to determine whether the detected cases of JD are due to new infections 
(acquired by introducing subclinically infected animal from another herd), or if the 
responsible strain type was already present in that herd (infected resident animal or 
environmental contamination) [43]. Therefore, there is value in conducting molecular 
epidemiological studies on Map. 
  
1.4.7 Strain typing method for analyzing Map strain diversity  
Phenotypic diversity is described based on the culture characteristics (colour/ 
pigmentation duration of growth) of Map strains. Map strains have been divided into 
two categories: sheep and cattle types [109,110]. Colonies of the sheep-types are 
pigmented and slow growing, whereas cattle-types are non-pigmented and fast 
growing [71]. Moreover, sheep-type strains are harder to cultivate than the cattle-
types strains [71]. Standard tests such as ELISA cannot discriminate between Map 
isolates collected from different hosts [109], which requires more detailed molecular 
analysis.  
Various molecular techniques are currently able to identify different Map 
strain-types with high confidence. Map epidemiological studies have been 
significantly impacted by genotyping techniques such as: restriction fragment length 
polymorphism, PFGE, multiplex PCR for IS900 loci, representational differentiating 
analysis (RDA)-PCR and PCR-restriction endonuclease analysis (PCR-REA) [109]. 
These methods can successfully differentiate between Map isolates belonging to the 
sheep- and cattle-type strains [109]. One caveat is that the above mentioned 
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molecular genotyping techniques are not capable of further resolving Map isolates 
into subgroups, because of limited variations in the genomes of different Map isolates 
[3]. More detailed methods used for further subtyping isolates include: variable 
number tandem repeat (VNTR) analysis, large sequence polymorphism typing, single 
nucleotide polymorphism typing, short sequence repeat (SSR) sequencing, 
mycobacterial interspersed repetitive unit (MIRU) analysis and matrix-assisted laser 
desorption/ionization-time of flight (MALDI-TOF) mass spectrometry 
[3,99,111,112]. These tools are useful for analyzing Map isolates from different 
geographical locations for analyzing isolates sources and dispersal patterns [109], and 
also for differentiating between the different strain types (sheep vs. cattle) [113].  
At present, sequencing of multiple SSRs (short repeating sequence of DNA) is 
widely used for genotyping Map isolates [99]. There are 11 physically distinct SSR 
loci present in the Map genome [3]. Among them, four SSR loci are highly 
polymorphic but stable, making them good candidates for typing Map isolates 
[3,50,114]. Determining the sequences of the four loci enables discrimination 
between different Map isolates by assigning a specific SSR combination to each 
isolate. Therefore, the development of SSR worldwide databases for analyzing 
molecular diversity of Map isolates is possible through the use of this method. The 
main disadvantage of multilocus SSR sequencing is the inaccurate assigning of Map 
genotypes due to problems associated with determining the DNA sequences of 
repeats using conventional methods [3]. However, this problem can be sometimes 
overcome by repeating the sequencing multiple times or by sequencing both the DNA 
strands [3]. Another cost effective method of genotyping Map isolates is to perform 
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fragment analysis using instrumentation that has single nucleotide resolution 
capability on target SSR regions instead of sequencing [115, 116]. This makes 
fragment analysis a reliable method for accurately determining the sizes of the DNA 
fragments, which in turn enables the calculation of the exact lengths of the SSRs that 
they contain [116]. Therefore, SSR analysis using different molecular methods can 
effectively provide valuable information regarding the source of infection, host 
specificity, and inter-/intra-species transmission capabilities [3,43,50,114,117-119].  
 
1.4.8 Map and CD 
CD occurs due to abnormal immune responses within the gastrointestinal 
mucosa in humans [120]. Previous studies have reported similarities between the 
pathologies of CD and JD, including the presence of Map in breast milk [121] and 
intestinal tissues of some CD patients [122]. In spite of pathological similarities 
between the two diseases and similar responses to anti-microbial drugs in animals 
with JD and humans with CD, argument regarding the association of Map with CD 
still exists [120]. In previous sections, the risk of humans acquiring Map from animal 
products has been discussed, but further research for substantiating transmission 
through dairy products is warranted as there is a possibility that Map is zoonotic in 
nature [123]. Collaborative multidisciplinary endeavors can further facilitate 
epidemiological studies regarding the association between these two intestinal 
diseases [123]. 
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1.5 Purpose of thesis 
The purpose of the research conducted here was to evaluate fast, reliable and 
inexpensive molecular methods for typing bacterial pathogens associated with the 
dairy industry. Different methods were used for sub-typing K. pneumoniae and Map 
isolates, the two pathogens that are the focus of the described work. Through the use 
of these molecular tools, information was gathered for investigating the molecular 
diversity of the two pathogens from the island of Newfoundland, which has not been 
reported previously.  
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Table 1.3.5.1: Brief description of antibiotics used for treating CM cases in Newfoundland 
 
Antibiotic Antibiotic class Mode of action Effective against Common mode of 
resistance 
 
Cephalothin/ 
Cefalotin 
 
 
β-lactam (first 
generation 
cephalosporin) 
 
Disrupts bacterial cell 
wall synthesis 
 
Staphylococcus 
isolates 
 
Enzymatic 
deactivation of  
antibiotic molecule 
Ceftiofur 
 
β-lactam (third 
generation 
cephalosporin) 
Disrupts bacterial cell 
wall synthesis 
Broad spectrum 
activity against 
Gram negative 
organisms 
Enzymatic 
deactivation of  
antibiotic molecule 
Pirlimycin Lincosamide Prevents protein synthesis 
in prokaryotes 
Gram positive 
bacteria 
Eliminates or reduces 
binding of antibiotic to 
cell target 
Novobiocin Aminocoumarin 
antibiotic 
 
Inhibits the chromosome 
replication 
Gram positive 
bacteria 
Point mutation in the 
DNA gyrase subunit 
Streptomycin Aminoglycoside Inhibits the protein 
synthesis of  bacteria 
Gram negative 
bacteria 
Enzymatic 
deactivation of  
antibiotic molecule 
Tetracycline Polyketide Inhibits the protein 
synthesis of  bacteria 
Gram negative 
bacteria 
Active efflux from the 
cell 
Trimethoprim 
sulfamethoxazole 
Combination of a 
sulfonamide antibiotic 
and a methoprim 
Inhibits the biosynthesis 
of essential tetrahydrofolic 
acid 
Bacterial, fungal 
and prokaryotic 
infections 
Alteration of 
metabolic pathway 
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Chapter 2: Klebsiella species associated with bovine mastitis in Newfoundland 
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Abstract 
Klebsiella spp. is a common cause of bovine mastitis, but information regarding 
its molecular epidemiology is lacking from many parts of Canada. By using mass 
spectrometry and partial sequencing of the rpoB gene, it was found that over a one year 
period, K. variicola and Enterobacter cloacae were misidentified as K. pneumoniae in a 
small number of clinical mastitis (CM) cases from Newfoundland. Results suggest that 
the currently used standard biochemical and phenotypic tests lack the sensitivity required 
to accurately discriminate among these three Gram negative bacteria. In addition, a single 
strain of K. variicola was associated with CM from one farm as demonstrated by random 
amplified polymorphic DNA (RAPD) PCR. To the best of our knowledge, K. variicola, 
which is normally found in the environment, has not been isolated previously from milk 
obtained from cows with CM. Therefore, it is possible that K. variicola was not detected 
in milk samples in the past due to the inability of standard tests to discriminate it from 
other Klebsiella species. (168 words) 
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2.1 Introduction 
Klebsiella pneumoniae is an important opportunistic human pathogen 
predominantly affecting immunocompromised or elderly human patients. Recently a 
hypervirulent K. pneumoniae strain was reported to be capable of causing fatal infections 
in healthy individuals [1]. Drug resistant forms of K. pneumoniae, especially those 
resistant to the β-lactam family of antibiotics are also a cause for concern due to the 
limited therapeutic options available for the treatment of such infections and the ability of 
these strains to rapidly spread and transfer the resistance phenotype [2-4]. In the dairy 
industry, K. pneumoniae is one of the known causes of primarily environment derived 
Klebsiella mastitis and has been the subject of numerous studies [3,5-7]. Clinical mastitis 
(CM) is classified as the condition where an animal displays the physical symptoms of 
mastitis [8] and milk production and quality is also affected [9]. Whilst most studies 
show limited impact of treatment, Schukken et al. [10] reported a significant increase in 
bacteriological cure after the use of antimicrobials for treating non-severe cases of 
Klebsiella associated CM. Mastitis adversely affects milk production and generally cows 
do not regain full production levels post recovery [11], leading to considerable economic 
losses. It has also been reported that the amount of decrease in milk production depends 
on the specific pathogen causing the infection and that Gram negative bacteria are 
responsible for greater reduction than Gram positive bacteria and other non-bacterial 
organisms [11-14]. Although, not routinely performed for diagnostic purposes, further 
characterization of bacterial isolates from infected animals helps to better identify the 
sources of the infection and to determine if herd infections are primarily clonal or 
polyclonal in nature [3,5,7]. These data allow clinicians to understand the nature of 
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transmission within herds and to implement targeted prevention strategies. Therefore, 
there is value in identifying the causative agent for quick action to prevent losses and also 
for surveillance purposes.  
In the current study, we used multiple methods to identify and analyze Gram 
negative coliforms associated with bovine CM from Newfoundland, Canada. Our results 
suggest that the currently used standard biochemical laboratory identification techniques 
were not sensitive enough to accurately identify the etiological agent in certain cases. In 
addition, we found that all CM cases from one farm were associated with K. variicola, 
which had been misidentified as K. pneumoniae using routine testing procedures.  
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2.2 Materials and Methods 
2.2.1 Ethics statement  
This study was carried out in cooperation with dairy farmers in the province and 
formalized by an agreement between their representative organization, the Dairy Farmers 
of Newfoundland and Labrador (NL), and the Chief Veterinary Officer for the Province 
of NL (HGW). Endangered species were not involved in the study and all samples were 
collected from the island of Newfoundland. The report is not intended to be a field study; 
instead it describes the application and accuracy of laboratory and molecular tests for the 
identification of coliform bacteria associated with bovine mastitis. Therefore, coordinates 
and details regarding the geographical origins of the samples are not included. Approval 
from an Institutional Animal Care and Use Committee (IACUC), or equivalent animal 
ethics committee, was not obtained as the samples used in the current study were 
obtained from routine veterinary diagnostic submissions unrelated to this research. The 
report is focused on the microbiological analysis following the isolation of bacteria from 
the milk samples, and did not directly involve any animals. 
 
2.2.2 Standard phenotypic/biochemical testing for pathogen identification 
Milk samples from animals with symptoms of CM were collected from 11 farms 
by the Animal Health Division, Department of Natural Resources, Government of NL 
between October, 2011 and October, 2012. Sample collection from dairy cattle was done 
through the expression of milk from the teats into a sterile collection container for 
submission to the diagnostic laboratory. For initial confirmation of CM status of the 
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animal, milk samples originating from infected quarters of the udder were subjected to 
the California mastitis test (CMT, Dairy Research Products Co., Canada). For isolation 
and phenotypic identification of CM associated bacteria, milk samples were streaked on 
tryptic soy agar with 5% sheep blood, MacConkey 3 agar with crystal violet and urea 
agar (Oxoid Ltd., Canada) as recommended (National Mastitis Council, 1999). To further 
characterize the isolates and to distinguish between members of Enterobacteriaceae, the 
IMViC test was performed using tryptic soy broth (I, Oxoid Ltd., Canada), methyl red 
(M), Voges-Proskauer (V) test (Becton Dickinson, Canada) and citrate test (C, Becton 
Dickinson, Canada). The M test differentiates Klebsiella spp. from Enterobacter cloacae 
and the I test differentiates between K. pneumoniae and K. oxytoca. Atypical results were 
reanalyzed using the API 20E identification kit (bioMérieux Canada, Inc.). Later on, the 
isolates were submitted to the Public Health Laboratory of the Government of NL (PHL-
NL, St. John‘s, NL, Canada) for classification using the matrix-assisted laser 
desorption/ionization-time of flight (MALDI-TOF) Biotyper System (Bruker Corp. 
USA). Certain isolates were also tested for their ability to metabolize adonitol using the 
API 50 CHE kit according to the manufacturer‘s instructions (bioMérieux Canada, Inc.). 
 
2.2.3 Antibiotic susceptibility testing 
All isolates were subjected to routine drug susceptibility testing using 
cephalothin, ceftiofur, streptomycin, tetracycline and trimethoprim sulfamethoxazole 
(TMP-sulfa) using the Kirby Bauer Disc Diffusion method. Minimum inhibitory 
concentrations were also determined for cephalothin, ceftiofur and tetracycline using the 
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Sensititer microdilution system (Trek Diagnostic Systems Inc.). All analyses were 
conducted according to the Clinical and Laboratory Standards Institute (CLSI) standards 
[15].  
  
2.2.4 Genotyping of isolates 
The isolates were successfully grown in nutrient broth (Becton Dickinson, Sparks, 
Md.) for molecular typing. Chromosomal DNA was extracted from 45 isolates and used 
for direct amplification and sequencing of the rpoB gene as described in a previous study 
[5] using the Thermo Scientific™ Phusion™ High-Fidelity PCR Kit. PCR products were 
subjected to DNA sequencing at the Centre for Applied Genomics, University of 
Toronto, Canada and the nucleotide sequences obtained were used to search the public 
database (http://blast.ncbi.nlm.nih.gov/Blast.cgi). The same 45 isolates were used for 
strain typing by random amplified polymorphic DNA (RAPD) PCR as described in 
previous studies [5,16]. The same primer pair (ERIC-2/1026) was designed to analyze 
different species of Klebsiella [17]. Images of DNA banding patterns obtained after 
agarose gel electrophoresis were analyzed using PyElph software [18] to prepare a 
presence/absence band matrix which was subsequently used to prepare a dendrogram 
using the neighbor joining method. Reproducibility of banding patterns for 45 isolates 
was also evaluated by repeating the entire gel analysis twice.  
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2.3 Results and Discussion 
2.3.1 Identification of K. pneumoniae and other isolates 
In the current study, Klebsiella spp. were detected in 61 milk samples that were 
routinely collected from cows with symptoms of CM from 11 farms in Newfoundland 
over a one year period. From these original 61 isolates that were identified as K. 
pneumoniae based on standard biochemical and phenotypic tests, only 45 could be re-
cultured for further examination. Subsequent analysis of all the isolates by MALDI-TOF 
Biotyper mass spectrometry reclassified two of the 45 isolates as Enterobacter cloacae 
and the remaining 43 as K. pneumoniae (Table 2.3.1.1). To determine/confirm genus and 
species identity, partial sequencing of the rpoB gene was carried out as it has been shown 
to be a good candidate to discriminate between coliforms associated with CM in previous 
studies [5]. The DNA sequences obtained were aligned after trimming and were used to 
build a dendrogram (Figure 2.3.1.1). In this third round of analysis, all CM associated 
samples from a single farm (farm 9) were identified as K. variicola and not K. 
pneumoniae.  In addition, two isolates from separate farms were confirmed to be E. 
cloacae, as suggested previously by MALDI-TOF analysis (Table 2.3.1.1). Therefore, K. 
pneumoniae, K. variicola and E. cloacae were identified to be associated with CM cases 
from 11 farms in the current study. 
Only K. variicola was isolated from cows with CM from farm 9, originating from 
the left hind quarter of the udders of two animals. One of the strains (KM-49) was re-
isolated from the same quarter during a second sampling conducted after a one month 
period. K. variicola was originally described to be unable to metabolize/ferment adonitol 
[20]. When the two K. variicola isolates from the current study were used in carbohydrate 
 43 
 
fermentation assays, results demonstrated that both isolates could ferment adonitol (Table 
2.3.1.2). Therefore, in the current study, K. variicola could only be identified based on 
rpoB sequencing, as all other methods, including the adonitol fermentation test failed to 
identify it.  
 
2.3.2 Molecular typing by RAPD analysis 
Many diverse K. pneumoniae strains are known to be present in dairy cattle feces 
and infections are normally linked to contaminated organic bedding material [16]. 
Genotyping techniques such as RAPD, multilocus sequence typing (MLST) and pulsed-
field gel electrophoresis (PFGE) have been used in the past to successfully analyze K. 
pneumoniae strain diversity associated with CM [5,21,22]. Of these, RAPD has many 
advantages as it is fast, relatively inexpensive and technically less demanding as 
compared to the other methods of analysis and was therefore chosen for the current study. 
Limited strain clustering was observed between the K. pneumoniae strains subjected to 
RAPD analysis (Figure 2.3.2.1A,B), which has also been reported in previous studies, 
suggesting an environmental source of the infection [16,19,21], with the exception of 
farm 6, where the two CM cases were associated with the same K. pneumoniae strain 
(Figure 2.3.2.1A-C). Therefore, it is possible that there was either direct or indirect 
animal to animal transmission on farm 6 or that a single environmental strain infected the 
two animals independently. Chromosomal DNA from the laboratory K. pneumoniae 
ATCC 15380 strain, was used as a control for RAPD analysis on two occasions, giving 
identical profiles, showing that the assay used is reliable enough for strain typing and all 
results were reproducible (Figure 2.3.2.1C). Examination of the two K. variicola isolates 
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from farm 9 demonstrated that they were identical, which could again suggest animal to 
animal transmission or that a single strain infected the two animals independently (Figure 
2.3.2.1A-C). Similar results were also reported in previous studies where RAPD 
demonstrated clear difference between Raoultella spp. and K. pneumoniae using the same 
pair of primers as used in the current study [5]. The RAPD assay was repeated to check 
for reproducibility and verify the DNA banding patterns between identical isolates 
(Figure 2.3.2.1C). In addition, the two E. cloacae strains identified in the current study 
from two different farms were not the same (Figure 2.3.2.1A and 2.3.2.1B).  
 
2.3.3 Antimicrobial activity and resistance profile 
All 45 isolates were also subjected to antimicrobial susceptibility testing using 
five drugs commonly used to treat Gram negative infections in veterinary medicine 
(cephalothin, ceftiofur, streptomycin, tetracycline and TMP-sulfa). CLSI guidelines were 
used for determining the breakpoint concentration for each antibiotic. Cephalothin 
resistance (a first-generation cephalosporin β-lactam) was only observed in the E. cloacae 
isolates. Combined results from these analyses are superimposed on the dendrogram 
shown in Figure 2.3.2.1B and 2.3.1.1, and are also included in Table 2.3.3.1. Varying 
profiles/degrees of resistance against streptomycin and tetracycline were observed for the 
K. pneumoniae isolates. In addition, three isolates from farm 1 (F1-1, F1-17 and F1-33) 
were resistant to TMP-sulfa and the two K. variicola isolates were sensitive to all the 
drugs tested (Figure 2.3.2.1B and Table 2.3.3.1).  
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2.3.4 Conclusion 
The insular nature of Newfoundland, its location and maritime climate pose 
unique challenges and environments for the management of dairy herds. In this study, 
bacteria were isolated from confirmed CM dairy animals from Newfoundland and were 
initially identified as K. pneumoniae using standard phenotypic laboratory testing 
protocols. MALDI-TOF finger printing further reclassified two isolates as E. cloacae, 
suggesting that this method is more sensitive than phenotypic biochemical analysis in 
discriminating between coliforms associated with CM [23]. MALDI-TOF has been used 
for proteomic analysis in several studies related to bovine mastitis [24,25]. MALDI-TOF 
is a rapid, precise and cost-effective method for bacterial identification compared to 
conventional phenotypic/biochemical techniques [26], but its sensitivity is dependent on 
the database used for matching the obtained spectra. Finally, partial rpoB gene 
sequencing revealed the presence of K. variicola from one farm, which could not be 
discriminated using the two previous methods. Similar results were also observed in 
previous studies where Klebsiella oxytoca, Klebsiella variicola and Raoultella planticola 
were isolated from environmental samples associated with CM [19]. Therefore, it is 
possible that the prevalence of K. variicola associated with CM might be under-reported, 
as the results suggest that routinely used identification tests are not sensitive enough to 
discriminate it from K. pneumoniae. 
K. pneumoniae is an opportunistic, environmental pathogen causing CM in dairy 
cattle [16] and it is very rare to see a dominant strain associated with a herd [5]. Farm 1, 
which had the highest incidence of CM over the period included in the study, displayed 
large amounts of variation in K. pneumoniae strains and only farm 6 had infections 
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caused by a single strain (Figure 2.3.2.1). Results also showed that both cases from farm 
9 were associated with a single strain of K. variicola (Figure 2.3.2.1) as it was the only 
bacterium cultured from the submitted milk samples (Table 2.3.3.1). The isolation of K. 
variicola from milk samples from cows with CM has not been reported previously as this 
organism is normally found in the environment [19]. In addition, K. variicola has also 
been previously isolated from plants and certain hospital settings [19,20]. Other reports 
have questioned the adonitol negative fermentation test for its ability to discriminate 
between K. variicola and other coliforms [27], which was also demonstrated by our 
results. The pathogenic potential of K. variicola is not well understood and there has been 
some concern in the ability to accurately detect it in humans. In a recent report, an 
incorrectly diagnosed K. variicola strain was responsible for human patient mortality, 
even though antibiotics were administered to which the isolate was sensitive under 
laboratory conditions [28]. To the best of our knowledge, this is the first report with 
evidence that an isolate of K. variicola can cause CM in dairy cattle, as it is normally 
found in soil and feed [19], and not in milk from infected animals. The relevance of the 
finding that one adonitol positive strain of K. variicola was responsible for both CM 
cases from a single farm will be investigated in future studies.   
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Table 2.3.1.1: Details of genus and species level identification of 45 coliform isolates 
obtained from milk samples from 11 Newfoundland dairy farms 
using the different identification methods described in the current 
study 
 
 
 
 
 
 
 
 
 
 
a 
Number of pure culture isolates from CM cases from each farm are shown in 
parenthesis 
b
 Final identification using a combination of the methods (biochemical/phenotypic tests, 
MALDI-TOF and rpoB sequencing) are shown 
c
 Farms showed the presence of cephalothin-resistant E. cloacae 
d 
E. cloacae could be identified using both MALDI-TOF and rpoB sequencing, but not 
by standard biochemical/phenotypic methods 
e 
All isolates from this farm were identified as adonitol fermenting K. variicola 
f 
K. variicola could be only identified by rpoB sequencing, but not by standard 
biochemical/phenotypic methods or by MALDI-TOF 
  
Farm of origin and 
number of isolates 
a
 
Identification 
b
 
 
Farm 1 (26) 
 
All K. pneumoniae 
Farm 2 (1) All K. pneumoniae 
Farm 3(5) 
c
 4 K. pneumoniae and  1 E. cloacae 
d
 
Farm 4 (2) All K. pneumoniae 
Farm 5(3) 
c
 2 K. pneumoniae and  1 E. cloacae
 d
 
Farm 6 (2) All K. pneumoniae 
Farm 7 (1) All K. pneumoniae 
Farm 8 (1) All K. pneumoniae 
Farm 9 (2) 
e
 All K. variicola  
f
 
Farm 10 (1) All K. pneumoniae 
Farm 11 (1) All K. pneumoniae 
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Figure 2.3.1.1: Phylogenetic tree derived from the rpoB partial gene sequences of all 45 
isolates built using the neighbour joining method in the Molecular Evolutionary Genetic 
Analysis (MEGA) package (version 6.06). Grouping of sequences of all the isolates were 
based on % confidence obtained by using a boot-strap value of 1000. The isolates were 
assigned labels based on the farm or origin (F1 to F11) followed by a number to identify 
the infected animal. The results of antibiotic susceptibility testing are also shown beside 
each isolate. S: sensitive, I: intermediate and R: resistant, based on Clinical and 
Laboratory Standards Institute (CLSI) interpretation. The S/I/R designations for each 
antibiotic are in the following order: cephalothin, ceftiofur, streptomycin, tetracycline and 
trimethoprim sulfamethoxazole, respectively. The isolates identified as K. variicola, E. 
cloacae and K. pneumoniae are also indicated. 
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Table 2.3.1.2: Results of tests using K. variicola isolates for their ability to metabolize select carbohydrates including 
adonitol, using the API 50 CHE kit after 24 hours of incubation (bioMérieux, Inc.) 
 
Sample K. pneumoniae (cont)
a
 F9-49 F9-58 
No. Test Colour
b
 Result
c
 Bubbles
d
 Colour Result Bubbles Colour Result Bubbles 
 
0 0 R ⁻ A R ⁻ A R ⁻ A 
1 GLY Y ⁺ P Y ⁺ P Y ⁺ A 
2 ERY R ⁻ A R ⁻ A R ⁻ A 
3 DARA R ⁻ A R ⁻ A R ⁻ A 
4 LARA Y ⁺ P Y ⁺ P Y ⁺ P 
5 RIB Y ⁺ A Y ⁺ P Y ⁺ A 
6 DXYL Y ⁺ P Y ⁺ P Y ⁺ P 
7 LXYL R ⁻ A R ⁻ A R ⁻ A 
8 ADO
e
 Y ⁺ P Y ⁺ A Y ⁺ A 
9 MDX R ⁻ A R ⁻ A R ⁻ A 
10 GAL Y ⁺ P Y ⁺ P Y ⁺ P 
11 GLU Y ⁺ P Y ⁺ P Y ⁺ P 
12 FRU Y ⁺ P Y ⁺ P Y ⁺ P 
13 MNE Y ⁺ P Y ⁺ P Y ⁺ P 
14 SBE Y ⁺ P Y ⁺ P Y ⁺ P 
15 RHA Y ⁺ A Y ⁺ P Y ⁺ A 
16 DUL R ⁻ A Y ⁺ P Y ⁺ P 
17 INO Y ⁺ P Y ⁺ A Y ⁺ P 
18 MAN Y ⁺ P Y ⁺ P Y ⁺ P 
19 SOR Y ⁺ P Y ⁺ A Y ⁺ P 
20 MDM R ⁻ A R ⁻ A R ⁻ A 
21 MDG Y ⁺ A Y ⁺ P Y ⁺ A 
22 NAG O ⁺ P O ⁺ P O ⁺ A 
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Sample K. pneumoniae (cont)
a
 F9-49 F9-58 
No. Test Colour
b
 Result
c
 Bubbles
d
 Colour Result Bubbles Colour Result Bubbles 
           
23 AMY R ⁻ A R ⁻ A R ⁻ A 
24 ARB Y ⁺ P Y ⁺ P Y ⁺ P 
25 ESC B ⁻ A B ⁻ P B ⁻ A 
26 SAL Y ⁺ P Y ⁺ P Y ⁺ P 
27 CEL Y ⁺ P Y ⁺ P Y ⁺ P 
28 MAL Y ⁺ P Y ⁺ P Y ⁺ P 
29 LAC Y ⁺ P Y ⁺ P Y ⁺ P 
30 MEL Y ⁺ P Y ⁺ P Y ⁺ P 
31 SAC Y ⁺ P Y ⁺ P Y ⁺ A 
32 TRE Y ⁺ P Y ⁺ P Y ⁺ P 
33 INU R ⁻ A R ⁻ A R ⁻ A 
34 MLZ R ⁻ A R ⁻ A R ⁻ A 
35 RAF Y ⁺ P Y ⁺ P Y ⁺ P 
36 AMD Y ⁺ P R ⁻ A R/O V A 
37 GLYG R ⁻ A R ⁻ A R ⁻ A 
38 XLT R ⁻ A R ⁻ A R ⁻ A 
39 GEN Y ⁺ P Y ⁺ P Y ⁺ A 
40 TUR R ⁻ A O ⁺ A R ⁻ A 
41 LYX R ⁻ A O ⁺ A R ⁻ A 
42 TAG Y ⁺ P Y ⁺ P Y ⁺ P 
43 DFUC R ⁻ A R ⁻ A R ⁻ A 
44 LFUC Y ⁺ P Y ⁺ P Y ⁺ A 
45 DARL Y ⁺ P Y ⁺ P Y ⁺ P 
46 LARL R ⁻ A R ⁻ A R ⁻ A 
47 GNT O ⁺ P O ⁺ P R ⁻ P 
48 2KG O ⁺ A O ⁺ P R/O V P 
49 5KG R ⁻ A Y/O V P O ⁺ P 
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a
 Laboratory strain K. pneumoniae ATCC 15380 was used in the analysis as a control  
b 
Colour: R = red and Y = yellow  
c Result: ‗+‘ = positive, ‗-‘ = negative and V = variable 
d 
Bubbles: A = absent and P = present 
e
 ADO = adonitol 
All interpretations are based on the manufacturer‘s recommendations   
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Figure 2.3.2.1: Molecular epidemiology of CM associated coliform bacteria isolated 
over a one year period from 11 dairy herds in Newfoundland. (A) Results from RAPD 
analysis employing 1.5% agarose gels to separate PCR products. Chromosomal DNA 
from a laboratory strain (K. pneumoniae ATCC 15380) was included as the positive 
control and sterile water functioned as negative control in the PCR assays. A 100 bp 
ladder (GeneDirex, USA, Cat No. DM001-R500) was used as the molecular weight 
marker. (B) Dendrogram based on RAPD results showing relatedness between strains 
was subjected to analysis in the current study. The dendrogram was generated by the 
neighbor joining method with the PyElph software. (A, B and C) The isolates were 
assigned labels based on the farm or origin (F1 to F11) followed by a number to identify 
the infected animal. The isolates determined to be E. cloacae (*) and K. variicola (
▲
) are 
also indicated. (B) The results from antibiotic susceptibility testing are also shown next to 
each isolate. S: sensitive, I: intermediate and R: resistant designations are assigned based 
on established break points. The S/I/R designations for each drug are in the following 
order: cephalothin, ceftiofur, streptomycin, tetracycline and trimethoprim 
sulfamethoxazole, respectively. The isolates identified as K. variicola and E. cloacae on 
further analysis are also indicated. (C) Re-analysis of strains by RAPD PCR to verify the 
accuracy of the assay and to confirm identities. PCR products generated independently 
for the second time using DNA from identical strains along with the positive control were 
reanalyzed, which confirmed results shown in A. 
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Table 2.3.3.1: Details regarding animal/farm ID, sample collection date, infected quarters sampled and California Mastitis 
Test (CMT) results. Information regarding bacterial identification by various methods (culture/biochemical 
tests, rpoB sequencing and MALDI-TOF), and antibiotic susceptibility test results (by minimum inhibitory 
concentrations and Kirby Bauer disc diffusion method according to CLSI guideline) are also included. 
Other organisms that were present in the samples besides K. pneumoniae based on biochemical/phenotypic 
methods are also indicated 
 
Lab 
ID 
Farm 
/Animal 
ID 
Collection 
Date 
Qu
a
 CMT
b
 Growth on 
MacConkey 3 
agar with 
crystal violet 
Identification of isolates by 
various methods
c
 
Antibiotic susceptibility 
Test result
e
 
Other 
organisms 
present (if 
any) rpoB Pheno
-type 
MALDI-TOF 
(Score value)
d
 
CEF
f
 CF
g
 S
h
 TE
i
 TS
j
 
               
1 001-007 6-Oct-11 LH 3+ Heavy  + + + (2.397) S S I S R Streptococcus 
uberis
k
 
2 002-001 6-Oct-11 RH NA Very light  + + + (2.526) S S S S S None 
3 001-022 10-Nov-11 LH 3+ Light  + + + (2.435) S S S S S Mixed
k
 
4 004-001 12-Nov-11 RF 2+ Very light  + + + (2.43) S S S S S None 
5 001-001 21-Nov-11 NG 3+ Heavy  + + + (2.18) S S I S S None 
6 001-002 17-Nov-11 LF 3+ Heavy  + + + (2.234) S S I S S None 
7 001-004 15-Nov-11 RF NA Light  + + + (2.456) S S I S S None 
10 003-006a 13-Dec-11 LH 3+ Scanty  + + + (2.382) S S R R S None 
12 005-003 3-Jan-12 RH 3+ Heavy  + + + (2.488) S S S S S None 
13 006-004 28-Dec-11 RF 2+ Heavy  + + + (2.446) S S R S S None 
14 003-002 6-Jan-12 RH NA Heavy  + + + (2.516) S S S S S None 
15 003-005 6-Jan-12 RH NA Heavy  + + + (2.504) S S R R S E. coli
k
 
16 007-001 17-Jan-12 RH NA Very  scanty + + + (2.334) S S S S S None 
17 001-015 16-Feb-12 RH NA Heavy  + + + (2.473) S S S S R None 
18 008-001 28-Feb-12 NG 2+ Light  + + + (2.236) S S S S S Mixed
k
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Lab 
ID 
Farm 
/Animal 
ID 
Collection 
Date 
Qu
a
 CMT
b
 Growth on 
MacConkey 3 
agar with 
crystal violet 
Identification of isolates by 
various methods
c
 
Antibiotic susceptibility 
Test result
e
 
Other 
organisms 
present (if 
any) 
rpoB Pheno
-type 
MALDI-TOF 
(Score value)
d
 
CEF
f
 CF
g
 S
h
 TE
i
 TS
j
 
               
19 001-014 25-Feb-12 RH NA Heavy  + + + (2.466) S S R S S None 
20 003-004 7-Mar-12 1Q 3+ Moderate  + + + (2.425) S S S S S None 
21 005-002 9-Mar-12 LF 2+ Very light  + + + (2.494) S S R S S None 
22 006-001 23-Mar-12 NA NA Scanty  + + + (2.385) S S R I S Mixed
k
 
25 003-006b 28-Mar-12 LH 3+ Scanty  + + + (2.444) S S R R S None 
27 001-009 5-Apr-12 RF NA Moderate  + + + (2.481) S S I S S None 
28 001-024 6-Apr-12 LF NA Moderate  + + + (2.485) S S I S S None 
29 001-011 15-Apr-12 RF NA Moderate  NA + + (2.528) S S I I S None 
30 001-006 10-May-12 RF NA Heavy  + + + (2.426) S S I S S None 
31 003-003 29-May-12 LH 3+ Heavy  - + - (2.027) R S S S S None 
32 001-008 16-May-12 RH NA Very light  + + + (2.39) S S S S S None 
33 001-010 20-May-12 LH NA Heavy  + + + (2.477) S S I S R None 
34 001-017 22-May-12 RF NA Very light  + + + (2.507) S S S S S None 
35 004-002 21-Jun-12 LH 3+ Light + + + (2.448) S S S S S Mixed
k
 
36 001-025 21-Jun-12 RH NA Scanty  + + + (2.481) S S R S S None 
38 001-023 23-Jul-12 RF NA Very scanty  + + + (2.443) S S R S S None 
39 005-004 2-Aug-12 NG 3+ Moderate  - + - (2.348) R S S S S coagulase 
Neg. 
Staphylococc
us
k
 
41 001-018 14-Aug-12 RF NA Very light + + + (2.483) S S S S S None 
42 001-027 13-Sep-12 RF NA Heavy + + + (2.396) S S S S S None 
43 001-012 13-Sep-12 RF NA Scanty  + + + (2.487) S S R S S None 
44 001-013 13-Sep-12 LH NA Scanty  + + + (2.481) S S S S S None 
45 001-016 13-Sep-12 LH NA Moderate  NA + + (2.423) S S S S S E.coli
k
 
46 001-019 13-Sep-12 RF NA Heavy  + + + (2.358) S S R R S Mixed
k
 
47 001-020 13-Sep-12 RF NA Scanty  + + + (2.499) S S S S S None 
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a
 Infected quarter of the udder sampled: RF = right forward, LF = Left forward, RH = right hind, LH = Left hind, 1Q = one quarter 
and NG = not given 
b
 California Mastitis Test result: N/A = not applicable (as milk samples were frozen upon arrival), 2+/ 3+ = positive result. The 
reaction of CMT is scored on a scale of 0 (mixture liquid, no precipitate) to 3 (almost-solid gel forms) where 2+ means distinct 
gel formation and 3+ is strong gel formation that tends to adhere to paddle 
c
 Identification of isolates by various methods: + = positive for K. pneumoniae and - = negative for K. pneumoniae 
d
 MALDI-TOF (Range of score value): 2.3-3.00 = highly probable species identification, 2.00-2.99 = secure genus identification, 
probable species identification 
e
 Antibiotic susceptibility Test result: S = sensitive, I = intermediate and R = resistant 
f
 CEF: ceftiofur 
g
 CF: cephalothin 
h
 S: streptomycin 
i
 TE: tetracycline 
j
 TS: trimethoprim sulfamethoxazole 
Lab 
ID 
Farm 
/Animal 
ID 
Collection 
Date 
Qu
a
 CMT
b
 Growth on 
MacConkey 3 
agar with 
crystal violet 
Identification of isolates by 
various methods
c
 
Antibiotic susceptibility 
Test result
e
 
Other 
organisms 
present (if 
any) 
rpoB Pheno
-type 
MALDI-TOF 
(Score value)
d
 
CEF
f
 CF
g
 S
h
 TE
i
 TS
j
 
               
48 001-026 13-Sep-12 RH NA Scanty  + + + (2.475) S S R S S None 
49 009-001a 20-Sep-12 LH 3+ Scanty  - + + (2.385) S S S S S None 
50 005-001 25-Sep-12 RH 1+ Heavy  + + + (2.447) S S S S S None 
53 006-006 13-Aug-12 LH NA Scanty  + + + (2.508) S S R S S None 
54 010-001 3-Oct-12 NG 3+ Light  + + + (2.422) S S S S S None 
55 001-029 1-Oct-12 LF NA Moderate  + + + (2.446) S S S S S None 
56 009-001b 16-Oct-12 LH 3+ Light  + + + (2.379) S S S S S None 
58 009-004 27-Oct-12 LH 2+ Moderate  - + + (2.372) S S S S S None 
59 001-030 10-Oct-12 LF NA Light  + + + (2.521) S S S S S None 
60 011-001 26-Oct-12 LH 3+ Scanty  + + + (2.449) S S S S S None 
61 001-031 19-Oct-12 RF NA Heavy  + + + (2.48) S S S S S None 
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k
 In some cases other organisms were also detected in the milk samples, which could not be identified in certain instances 
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Chapter 3: Typing of Mycobacterium avium subspecies paratuberculosis isolates 
from Newfoundland using fragment analysis 
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Edward Island). Initial diagnosis and establishment of Map cultures for subsequent 
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Portions of this chapter will be included in a manuscript currently under 
preparation. 
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Abstract 
Short sequence repeat (SSR) typing of Mycobacterium avium subspecies 
paratuberculosis (Map) isolates is one of the most discriminatory methods available for 
genotyping this pathogen. Currently used techniques have challenges in analyzing 
mononucleotide repeats >15 bp, which include some of the Map SSRs. Fragment analysis 
is a relatively simple technique, which can measure the size of DNA fragments and can 
be used to calculate the repeat length of the target SSR loci. In the present study, 
fragment analysis was used to analyze 4 Map SSR loci known to provide sufficient 
discriminatory power to determine the relationship between Map isolates. Eighty-eight 
Map isolates from 18 animals from the island of Newfoundland were successfully 
genotyped using fragment analysis. To the best of our knowledge, this is the first report 
on Map SSR diversity from Newfoundland dairy farms. In addition, multiple Map SSR-
types were isolated from a single animal in many cases, which is not a common finding. 
(154 words) 
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3.1 Introduction 
Mycobacterium avium subspecies paratuberculosis (Map) is a slow growing 
bacterium and is the cause of Johne‘s disease, which is associated with chronic 
debilitating granulomatous enteritis that affects the small intestine of cattle, sheep, goats, 
farmed deer and other ruminants [1-6]. Johne‘s disease is a major cause of concern to the 
dairy industry and there is also some concern regarding the association of Map with 
Crohn‘s disease in humans [7-9]. Treatment of dairy animals infected with Map is 
impractical because it can be only achieved by using a combination of antibiotics, many 
of which are very expensive, not licensed for food animals and require long term dosing 
[10]. Therefore, infected animals are culled, which is also a part of the Johne‘s disease 
control/management practice [5]. Because diagnosis is very challenging early on in the 
disease process, animals can still get infected by Map through exposure to shedding 
asymptomatic animals and environmental contamination [11,12]. The long incubation 
period of Map and the non-specific clinical symptoms in infected animals makes the 
diagnosis, management and control of Johne‘s disease difficult. To decrease the spread of 
Johne‘s disease, surveillance programs are being established throughout the world for 
determining the sources of infections, the prevalence of the causative agent and the 
relationship(s) between Map isolates from dairy farms. Studies are also being conducted 
to examine the role of host genetics in determining the susceptibility of individual 
animals and their clinical course once infected. Such programs are vital for devising 
effective control strategies against this devastating disease [13].  
More recently, there have been a number of reports on the molecular 
epidemiology of Map. In previous studies, single or combined molecular methods have 
 65 
 
been used to obtain epidemiological data regarding Map strain types [14-16]. Most of the 
previously used strain typing methods are expensive, time consuming, and lack 
discriminatory capabilities [14,15,17]. Despite these limitations, the information obtained 
from such studies is essential for identifying sources and transmission routes more 
accurately. When combined with information on host genetics, strain typing studies can 
also be used to determine strain pathogenicity and host resistance. Molecular techniques, 
especially DNA-based short-sequence-repeat (SSR) analysis, have been shown to be 
powerful tools for discriminating between Map isolates at the genetic level 
[5,14,15,16,18]. Due to differences in the numbers of nucleotide repeats associated with 
SSRs from different Map isolates, the relatedness and prevalence of Map strains can be 
monitored within/between farms and the environment [14,18]. One major problem with 
conventional methods for SSR analyses such as the use of Sanger sequencing, is that they 
are prone to artifacts and failure due to challenges associated with determining the DNA 
sequences of the repeats, with the most recent technology being capable of analyzing 
repeats up to 15 bp using a mass spectrometry based approach [17]. Therefore, there is a 
need to develop cheap, reliable and reproducible methods for Map SSR analysis, which 
can accurately measure repeats totaling over 15 bp in length.  
Recently, DNA fragment analysis of PCR products obtained using fluorescently 
labeled primers was used for typing Map SSRs [16]. There is significant movement of 
animals within the Newfoundland dairy industry, with new animals being brought onto 
the island for entry into the production chain. In addition, some heifers are also shipped 
to other Atlantic Canada provinces on the mainland for rearing, before they return as 
adult cows, as it is economically more feasible to do so in some situations. Therefore, 
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there is considerable interest in analyzing the diversity Map isolates infecting animals 
from the island for comparison to those found elsewhere in North America. To achieve 
this, in the current study we used fragment analysis to analyze Map isolates from five 
Newfoundland dairy farms. 
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3.2 Materials and Methods 
3.2.1 Ethics statement 
The described study was carried out under a formal agreement between the Dairy 
Farmers of Newfoundland and Labrador (NL) and the Chief Veterinary Officer for the 
Province of NL (HGW). The study was approved by the Institutional Animal Care 
Committee (IACC, Memorial University of Newfoundland) as an ‗A‘ rated protocol 
because the samples used in the study were obtained from routine veterinary diagnostic 
submissions unrelated to this research. The report describes laboratory microbiological 
analysis and did not directly involve any animals. 
 
3.2.2 Media, reagents and culture conditions 
All reagents and media used in the study were purchased from Sigma Aldrich, 
Fisher Scientific or VWR International, Canada, unless otherwise mentioned. DNA 
oligonucleotide primers were purchased from Integrated DNA Technologies (USA). 
Fecal samples from 18 animals displaying varying clinical symptoms of Johne‘s disease 
or suspected of being infected (Table 3.2.2.1) were collected by the Animal Health 
Division, Department of Natural Resources, Government of NL and were sent to the 
Atlantic Veterinary College, UPEI for diagnosis. Trek-ESP II liquid culture using Trek 
ESP Para-JEM media (Thermo Scientific, Canada) was used to culture Map from bovine 
fecal samples as described previously [19], and mycobacteria were verified by acid-fast 
staining. Map cultures were grown at 37°C. To confirm the presence of Map in the 
cultures, chromosomal DNA was isolated using the Tetracore Map extraction system and 
was used as a template along with the Tetracore VetAlert
TM
 Johne‘s Real-Time PCR kit 
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as per the manufacturer‘s instructions (Tetracore, USA). After the described analysis, the 
culture samples were stored as frozen glycerol stocks and were sent to the Memorial 
University of Newfoundland for further analysis. 
The culture samples from UPEI were streaked out onto Middlebrook 7H11 agar 
plates supplemented with oleic acid-albumin-dextrose-catalase (OADC) and mycobactin 
J (2 mg/L, Allied Monitor, USA) to obtain isolated Map colonies as described previously 
[14]. The PANTA (polymyxin B, amphotericin B, nalidixic acid, trimethoprim and 
azlocillin) antibiotic mixture was also added to the medium to prevent the growth of other 
contaminating microorganisms [20]. The plates were incubated for 4-6 months until 
minute colonies were observed, which were confirmed to be Map by acid-fast staining. 
Three to five isolated colonies from each plate (corresponding to each animal) were then 
used to inoculate separate 5 mL Middlebrook 7H9 broth cultures supplemented with 
albumin-dextrose-catalase (ADC) and mycobactin J (2 mg/L). To avoid the clumping of 
cells, culture tubes contained sterile glass beads and were incubated with agitation. 
Growth was observed for 88 isolates (3-5 isolates sampled from each animal) after 2-3 
months of incubation based on an increase in the turbidity of the cultures, which were 
then used to prepare glycerol stocks for storage and for chromosomal DNA isolation as 
described below. Acid-fast staining was performed at different stages to ensure that the 
cultures were axenic. 
 
3.2.3 Chromosomal DNA isolation, SSR sequencing and fragment analysis 
The QIAamp DNA Mini kit (Qiagen, Canada) was used for isolating 
chromosomal DNA from the remaining 3.5 ml 7H9 cultures from above using 0.1 mm 
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zirconia silica beads and a SpeedMill PLUS homogenizer (Analytik Jena, Germany) 
according to the manufacturer‘s recommendations. All PCR reactions were performed 
using the Phusion High-Fidelity PCR Kit along with 3% DMSO and the GC buffer (New 
England Biolabs, Inc.). PCR products were visualized by agarose gel electrophoresis, 
purified using the EZ-10 Spin Column PCR Products Purification Kit (Bio Basic, 
Canada) and were sent for DNA sequencing or fragment analysis to The Centre for 
Applied Genomics (TCAG), University of Toronto, Canada. The four SSR loci (L1-L4) 
previously shown to provide good discriminatory power for subtyping Map isolates were 
chosen for analysis [5,14]. The DNA sequences of the four SSR repeats were determined 
for three Map isolates obtained as part of a separate study as described previously [5,14]. 
The sequences of the 4 loci for the Map K10 (genome sequenced strain) were obtained 
from the database [21]. Sequences were obtained to determine the exact numbers of the 
SSR repeats for each of the strains, for the strains to be used as standards (S) during 
fragment analysis.  
For fragment analysis, four primer pairs were designed which were specific for 
each locus to give PCR products ranging from 127 to 255 bp, and one primer from each 
pair was labeled with 6-fluorescein amidite (6-FAM). Primers that have the 6-FAM dye 
next to a guanine base near the 5' end can have decreased fluorescence. Therefore, the 
most appropriate of either the forward or the reverse primer from each pair was labeled to 
avoid any complications. The DNA sequences of the primers used for obtaining PCR 
products for fragment analysis for each locus were as follows: L1 (F: 
GGTGTTCGGCAAAGTCGTT/R: TTGACGATCACCAGCCCG), L2 (F: 
TCGCCTCAGGCTTTACTGAT/R: CACGTAGGTCCGCTGATGA), L3 
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(AGGCCTTCTACGTGCACAAC/R: GAGATGTCCAGCCCTGTCTC) and L4 (F: 
CTCGTGGAAACCCTCGAC/R: GGTGCTGAAATCCGGTGT). Unpurified PCR 
products were sent to the TCAG facilities for fragment analysis using the ABI 3730XL or 
3100 capillary electrophoresis instruments using the GeneScan™ 500 ROX™ Size 
Standard, which is capable of accurately sizing DNA fragments ranging from 35 to 500 
bp (http://www.tcag.ca/facilities/geneticAnalysis.html). The Peak Scanner software v1.0 
(Applied Biosystems) was used to analyze the fragment profiles/peaks to determine the 
sizes of the DNA fragments, which were used to calculate SSR copy numbers. 
Comparison of the fragment sizes from Newfoundland isolates with those from the 
sequenced standards, which were included in every fragment analysis run, enabled the 
determination of the exact copy number of each repeat at the target SSR loci. If fragment 
analysis showed a difference in 1 bp for L1 and L2 (mononucleotide repeats), and 3 bp 
for L3 and L4 (tri-nucleotide repeats) between a fragment from an isolate and a standard, 
it implied that there was a difference in one copy of the repeat between the two strains 
(Table 3.2.3.1). In total 44 SSR-types were assigned on the basis of the combinations of 
alleles for each locus and the information was used to build a dendrogram using the 
BioNumerics 7.1 program (Applied Maths, Inc., USA). The unweighted pair group 
method with arithmetic mean was used to create a minimum spanning tree using the same 
program; this portrays the level of divergence between strains utilizing pairwise genetic 
distances [22]. It was possible to directly compare SSRs up to 14 bps from the current 
study with those reported previously. Longer SSRs identified in the current study were 
deemed to be similar, but not the same as those from previous studies which were 
reported as >14 bp.  
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3.3 Results and Discussion 
3.3.1 Fragment analysis on Map isolates 
The sequencing of DNA repeats using conventional methods is often challenging 
and is prone to artifacts, which is further exacerbated by repeats with high GC content 
such as those found in Map. In addition, currently available technologies can only 
determine the lengths of repeats up to ~15 bp accurately and often longer repeats cannot 
be measured [17]. In the case of Map, it has been previously reported that the analysis of 
4 SSRs (L1/L2: mononucleotide, and L3/L4 trinucleotide) provides enough sequence 
information for strain discrimination, and that one of the mononucleotide SSRs (L1) can 
be >14 bp in length depending on the isolate [5,14]. In our own studies we found that the 
sequencing of PCR products containing SSRs 14 bp using the Sanger method was not 
straightforward (Figure A.1). Previous reports also describe similar problems where the 
L1 SSR had sequencing errors during analysis, leading to the misinterpretation of repeat 
lengths [17]. Therefore, to overcome issues associated with the analysis of Map SSRs, we 
adapted fragment analysis as a method to analyze Map isolates from 5 dairy farms from 
Newfoundland [16]. Fecal samples were collected from 18 animals, some of which 
showed clinical signs of Johne‘s disease, displayed an immune response against Map in 
milk samples collected during previous surveys or were suspected of being infected 
(Table 3.2.2.1). The samples were processed to obtain 18 primary fecal cultures, which 
were then used to establish 88 axenic cultures for use in the current study. 
 Before using the fragment analysis based approach, three Map isolates (referred to 
as control strains from hereon) that were obtained as part of another study were subjected 
to SSR sequencing using the Sanger method as described previously [5,14,15,18]. 
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Multiple sequencing runs were carried out until we could reproducibly sequence across 
the SSRs (Figure A.1). This was done to determine the exact numbers of repeats at the 
four SSR loci for the respective isolates for subsequent use as standards for comparisons 
during fragment analysis. Again, we could only obtain accurate and reliable sequences 
for SSRs smaller than 14 bp using Sanger method (Figure A.1). The lengths of the SSRs 
for the K10 strain were already known (L1:19, L2:10, L3:5 and L4:5) because its genome 
has been sequenced [21]. Next, the four loci specific sets of fluorescently labeled primers 
were used in separate PCR reactions along with chromosomal DNA as template from the 
control strains described above. Since the exact numbers of SSRs present in each PCR 
product were known from Sanger sequencing for the control strains, they were included 
as size standards in all future fragment analysis experiments. 
Chromosomal DNA was isolated from 88 axenic Map cultures established using 
samples from Newfoundland, and were used as template to obtain fluorescently labeled 
PCR products for fragment analysis. Comparison of each SSR PCR product with the 
respective standards described above provided accurate data regarding the copy number 
of the repeats at each locus for all 88 isolates in a short period of time (Table 3.2.3.1). In 
the current study we were also able to analyze L2, which was not possible in a previous 
report that also used fragment analysis [16]. Control strains were reanalyzed by fragment 
analysis to rule out ambiguities. After excluding Map isolates from the same animal with 
identical SSR profiles, a total of 70 isolates with 44 different SSR-types (M1-M44) were 
identified from 18 animals from 5 different Newfoundland farms (Table 3.3.1.1). In 
addition, in many cases Map with multiple SSR-types were isolated from the same 
animal (Table 3.2.3.1). 
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3.3.2 Comparison with other epidemiological data 
The most predominant SSR-types were M1 and M4, which were isolated from 5 
separate animals each from different farms (Table 3.3.1.1 and Figure 3.3.2.1). One reason 
for this observation could be the random distribution of Map SSR-types within farms 
following animal movement between farms, which is known to increase the probability 
of detecting multiple and/or similar strains on the farms involved [23]. Most SSR-types in 
the population were closely related to M4, differing from it by only 1-2 SSR loci (Figure 
3.3.2.2). Overall, some farm based clustering of isolates was observed (Figure 3.3.2.1). A 
high level of diversity was seen in isolates from farm A, which alone had 23 different 
SSR-types out of the 44 detected. Eight SSR-types present on farm A were also present 
on other farms (C, E, F; Figure 3.3.2.1) suggesting possible inter herd transmission or a 
common source of infection. SSR-types from farm D were not detected on other farms, 
although they showed some level of genetic similarity with isolates from farm C (Figure 
3.3.2.1). Animals from farm F did not exhibit any clinical signs of Johne‘s disease, but 
tested positive for Map with unique SSR-types, in addition to SSR-types found on other 
farms also (Figure 3.3.2.1). 
 
3.3.3 Conclusions 
The resolution of long SSRs by fragment analysis and the recent report showing 
that the technique can be multiplexed for analyzing multiple SSRs [16] further 
demonstrates the power and versatility of this technique for typing Map isolates. Future 
studies using techniques with better resolution capabilities and samples from other 
regions of North America will help to explain if the previously unidentified Map SSRs-
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types reported in the current study are unique to Newfoundland or if they were not 
detected due to technical limitations. In addition, results from the current study also 
indicated Map co-infection with multiple genotypes within a single animal, which has 
been reported as a rare event [18]. The isolation of multiple genotypes from the same 
animal could be due to evolving SSR-types as a result of the instability associated with 
long DNA repeats [24]. Alternatively they might represent true co-infections due to the 
movement of animals within Newfoundland and between Atlantic Canada, which is 
important in terms of source tracking and the status of the animals involved. As part of 
another study we were also able to obtain Map isolates with different SSR copy numbers 
from single animals from a farm in Atlantic Canada (unpublished data). Therefore, 
studies are currently underway to address the significance and implications of these 
findings. 
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Table 3.2.2.1: Details of 18 animals from Newfoundland regarding assigned 
identification numbers (IDs) and status of the animal from which 
the primary Trek-ESP II liquid cultures were derived 
 
Farm/animal 
ID
a
 
Animal 
status/symptoms
b
 
 
A-001 Clinical signs 
A-002 Clinical signs 
A-005 Clinical signs 
A-006 Milk Positive for Map 
A-007 Milk Positive for Map 
A-008 Milk Positive for Map 
A-009 Milk Positive for Map 
A-010 Milk Positive for Map 
A-011 Clinical signs  
C-001 Clinical signs 
C-002 Clinical signs 
C-003 Clinical signs 
C-004 Clinical signs 
C-005 Clinical signs 
D-001 Clinical signs 
E-001 Clinical signs 
F-001 Normal 
F-002 Normal 
 
a 
The first letter denotes the farm of origin followed by a identification number assigned 
to each respective animal (ID: Identity) 
b
 The status of each animal sampled for Trek-ESP II liquid culture for Map analysis is 
included. Animals were either asymptomatic (normal), showed clinical signs of Johne‘s 
disease or had milk samples which showed a positive immune response against Map 
during previous surveys 
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Table 3.2.3.1: Fragment analysis results for the 4 SSR loci of all 88 Map isolates 
derived from 18 Newfoundland animals. Strain types were 
designated as M1-M44 based on their unique SSR combinations 
 
Farm/animal/isolate 
ID
a
 
DTP
b
 
L-1 
(G)
c
 
L-2 
(G)
c
 
L-3 
(GGT)
c
 
L-4 
(TGC)
c
 
SSR- 
Type 
       
A-001-1 27 21 10 5 5 M20 
A-001-2 27 14 10 5 5 M1 
A-001-3 27 19 11 5 5 M21 
A-001-4 27 16 11 5 5 M2 
A-001-5 27 20 9 5 5 M22 
A-003-1
d
 32 17 11 5 5 M3 
A-003-2
d
 32 17 11 5 5 M3 
A-003-3
d
 32 17 11 5 5 M3 
A-003-4 32 11 10 5 5 M16 
A-003-5 32 11 11 5 5 M4 
A-005-1
d
 13 11 12 5 5 M5 
A-005-2 13 20 10 5 5 M23 
A-005-3 13 16 11 5 5 M2 
A-005-4
d
 13 11 12 5 5 M5 
A-005-5 13 15 10 5 5 M11 
A-006-1 28 12 10 5 5 M15 
A-006-2 28 16 12 5 5 M10 
A-006-3 28 7 10 5 5 M13 
A-006-4 28 13 11 5 5 M14 
A-006-5 28 16 12 5 5 M10 
A-007-1
d
 22 11 11 5 5 M4 
A-007-2 22 10 10 5 5 M33 
A-007-3 22 15 10 5 5 M11 
A-007-4 22 14 10 5 5 M1 
A-007-5
d
 22 11 11 5 5 M4 
A-008-1 46 18 11 5 5 M12 
A-008-2 46 16 10 5 5 M19 
A-008-3 46 20 11 5 5 M34 
A-008-4 46 7 10 5 5 M13 
A-008-5 46 7 11 5 5 M35 
A-009-1
d
 36 13 11 5 5 M14 
A-009-2 36 11 11 5 5 M4 
A-009-3 36 14 11 5 5 M36 
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Farm/animal/isolate 
ID
a
 
DTP
b
 
L-1 
(G)
c
 
L-2 
(G)
c
 
L-3 
(GGT)
c
 
L-4 
(TGC)
c
 
SSR- 
Type 
       
A-009-4 36 18 11 5 5 M12 
A-009-5
d
 36 13 11 5 5 M14 
A-010-1
d
 49 12 10 5 5 M15 
A-010-2 49 15 9 5 5 M37 
A-010-3
d
 49 12 10 5 5 M15 
A-010-4 49 12 9 5 5 M17 
A-010-5 49 16 11 5 5 M2 
A-011-1
d
 8 15 11 5 5 M18 
A-011-2 8 11 11 5 5 M4 
A-011-3
d
 8 15 11 5 5 M18 
A-011-4 8 10 11 5 5 M44 
A-011-5 8 15 10 5 5 M11 
C-001-1
d
 28 14 10 5 5 M1 
C-001-2
d
 28 14 10 5 5 M1 
C-001-3 28 15 11 5 5 M18 
C-001-4
d
 28 11 11 5 5 M4 
C-001-5
d
 28 11 11 5 5 M4 
C-002-1 28 5 11 4 4 M6 
C-002-2
d
 28 14 10 5 5 M1 
C-002-3
d
 28 14 10 5 5 M1 
C-002-4 28 6 12 4 4 M24 
C-002-5 28 5 11 4 4 M6 
C-003-1
d
 17 15 14 5 5 M7 
C-003-2 17 13 13 5 5 M8 
C-003-3
d
 17 15 14 5 5 M7 
C-003-4 17 6 13 5 5 M25 
C-003-5 17 13 13 5 5 M8 
C-004-1 32 8 11 4 5 M26 
C-004-2
d
 32 9 12 4 5 M9 
C-004-3 32 9 11 4 5 M27 
C-004-4
d
 32 9 12 4 5 M9 
C-004-5
d
 32 9 12 4 5 M9 
C-005-1 40 11 10 5 5 M16 
C-005-2 40 10 13 4 5 M28 
C-005-3 40 11 10 5 5 M16 
C-005-4 40 10 12 4 5 M29 
C-005-5 40 11 10 5 5 M16 
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Farm/animal/isolate 
ID
a
 
DTP
b
 
L-1 
(G)
c
 
L-2 
(G)
c
 
L-3 
(GGT)
c
 
L-4 
(TGC)
c
 
SSR- 
Type 
       
D-001-1 13 5 15 4 4 M30 
D-001-2 13 7 15 4 4 M31 
D-001-3 13 7 14 4 4 M32 
E-001-1 18 11 11 4 5 M38 
E-001-2 18 18 11 5 5 M12 
E-001-3 18 15 10 5 5 M11 
E-001-4 18 11 9 5 5 M39 
E-001-5 18 7 11 6 5 M40 
F-001-1 19 18 9 5 5 M41 
F-001-2 19 19 9 5 5 M42 
F-001-3 19 16 7 5 5 M43 
F-001-4 19 12 9 5 5 M17 
F-001-5 19 12 10 5 5 M15 
F-002-1 35 16 10 5 5 M19 
F-002-2 35 14 10 5 5 M1 
F-002-3 35 16 10 5 5 M19 
F-002-4 35 16 11 5 5 M2 
F-002-5 35 17 11 5 5 M3 
       
 
a 
The first letter denotes the farm of origin followed by a number assigned to the animal 
and the last number corresponds to the single colony/isolate from 7H11 plates that were 
used in the analysis. In every case, 3-5 colonies were picked for analysis from each 
7H11 plate based on colony morphology and acid fast staining results
 
b 
DTP: Days to positive, days of incubation after which growth was detected in the 
automated Trek-ESP II liquid culture system 
c
 Genotyping of SSRs (mononucleotide or trinucleotide) for the four loci (L): locus 1 (G 
repeats), locus 2 (G repeats), locus 3 (GGT repeats) and locus 4 (TGC repeats). The 
copy numbers of each SSR for all isolates are shown 
d
 Map with identical SSR-types isolated from the same animal are indicated and were 
treated as duplicates during subsequent analysis  
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Table 3.3.1.1: Details of the 44 Map SSR-types that were isolated from five 
Newfoundland farms in the current study and were analyzed using 
fragment analysis 
 
L-1 
(G)
a
 
L-2  
(G)
a
 
L-3 
(GGT)
a
 
L-4 
(TGC)
a
 
SSR-type
b
 
No. of 
Animals with 
SSR-type
c
 
Farm ID
d
 
       
14 10 5 5 M1 5 A(2), C(2), F(1) 
16 11 5 5 M2 4 A(3), F(1) 
17 11 5 5 M3 2 A(1), F(1) 
11 11 5 5 M4 5 A(4), C(1) 
11 12 5 5 M5 1 A(1) 
5 11 4 4 M6 2 C(2) 
15 14 5 5 M7 1 C(1) 
13 13 5 5 M8 1 C(1) 
9 12 4 5 M9 1 C(1) 
16 12 5 5 M10 1 A(1) 
15 10 5 5 M11 4 A(3), E(1) 
18 11 5 5 M12 3 A(2), E(1) 
7 10 5 5 M13 2 A(2) 
13 11 5 5 M14 2 A(2) 
12 10 5 5 M15 3 A(2), F(1) 
11 10 5 5 M16 2 A(1), C(1) 
12 9 5 5 M17 2 A(1), F(1) 
15 11 5 5 M18 2 C(1), A(1) 
16 10 5 5 M19  2 A(1), F(1) 
21 10 5 5 M20 1 A(1) 
19 11 5 5 M21 1 A(1) 
20 9 5 5 M22 1 A(1) 
20 10 5 5 M23 1 A(1) 
6 12 4 4 M24 1 C(1) 
6 13 5 5 M25 1 C(1) 
8 11 4 5 M26 1 C(1) 
9 11 4 5 M27 1 C(1) 
10 13 4 5 M28 1 C(1) 
10 12 4 5 M29 1 C(1) 
5 15 4 4 M30 1 D(1) 
7 15 4 4 M31 1 D(1) 
7 14 4 4 M32 1 D(1) 
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L-1 
(G)
a
 
L-2  
(G)
a
 
L-3 
(GGT)
a
 
L-4 
(TGC)
a
 
SSR-type
b
 
No. of 
Animals with 
SSR-type
c
 
Farm ID
d
 
       
10 10 5 5 M33 1 A(1) 
20 11 5 5 M34 1 A(1) 
7 11 5 5 M35 1 A(1) 
14 11 5 5 M36 1 A(1) 
15 9 5 5 M37 1 A(1) 
11 11 4 5 M38 1 E(1) 
11 9 5 5 M39 1 E(1) 
7 11 6 5 M40 1 E(1) 
18 9 5 5 M41 1 F(1) 
19 9 5 5 M42 1 F(1) 
16 7 5 5 M43 1 F(1) 
10 11 5 5 M44 1 A(1) 
       
 
a
 The number/copies of repeats for each SSR detected in the current study are indicated.  
b
 SSR-types were designated as M1-M44 based on the copy number of the repeats for the 
4 SSR loci used in the analysis.
  
c
 The total number of animals are indicated from which Map with the respective SSR-
types (M1-M44) were isolated 
d 
The assigned identity (ID) of each farm is indicated by capital letters followed by the 
number of animals from that farm from which Map with the specific SSR-type was 
isolated. For example, A(3) implies that 3 individual animals from Farm A had Map 
with the specific SSR-type 
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Figure 3.3.2.1: Dendrogram representing the genetic relationship between all Map isolates 
based on the 4 SSRs loci used in the analysis. The dendrogram was built using the 
unweighted pair group method with arithmetic mean (UPGMA) using the BioNumerics 
7.1 multilocus sequence typing program. Genetic distance (Categorical coefficient) is 
indicated at the top of the dendrogram. SSR-types, number of isolates (n) and farm ID are 
displayed to the right side of the dendrogram. 
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Figure 3.3.2.2: Minimum spanning tree (MST) based on the SSR profiles of the 4 loci for 
all 44 SSR-types identified in the current study. The circles represent the different strain 
types generated by the BioNumerics 7.1 multilocus sequence typing program. The number 
of Map isolates (after omitting duplicates from the same animal) belonging to each SSR-
type is shown in parenthesis within the respective circles. Thick lines represent only one 
variation amidst the 4 loci, whereas thin lines represent 2 differences between the 4 loci, 
the latter of which is indicated. 
 86 
 
Chapter 4: Summary 
4.1 K. pneumoniae 
The purpose of the research conducted in chapter two was to apply molecular 
methods for identifying and strain typing Gram-negative bacteria isolated from animals 
with CM, thus broadening our knowledge regarding the diversity of Klebsiella spp. 
present on a subset of Newfoundland dairy farms. Strain typing was performed using 
RAPD analysis, which is a quick and cost-effective method and provided valuable 
information regarding genetic relationship between different Klebsiella isolates. 
Furthermore, drug sensitivity profiles of the isolates were also determined and mapped on 
to the dendrograms, but relationships between resistance profiles/patterns and 
transmission  were not observed. 
Through the use of mass spectrometry and gene sequencing, it was found that K. 
variicola and E. cloacae were misidentified as K. pneumoniae in a small number of CM 
cases from Newfoundland, during the one year study. K. variicola, which is normally 
considered as an environmental and hospital-acquired opportunistic bacterium [1], had 
not been isolated previously from animals with CM. Therefore, the standard tests to 
discriminate Klebsiella species are not sensitive enough for detecting K. variicola and 
other Gram negative pathogens. Overall, polyclonal infection patterns were observed in 
the majority of farms, and a predominant or overrepresented strain was not observed in 
any of the cases. In the future, whole genome sequencing of the K. variicola isolates will 
be conducted, which will help to reveal the virulence factors and pathogenicity associated 
mechanisms present in this newly emerging pathogen [2]. 
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4.2 Map 
The goal of the research described in chapter three was to apply a cost effective 
molecular method (fragment analysis) for SSR typing of Map strains isolated from five 
dairy herds in Newfoundland. The information obtained using this method was useful for 
differentiating/subtyping Map strains and for analyzing molecular diversity.  
SSR typing of Map isolates by mass spectrometry and Sanger sequencing are 
currently the most discriminatory genotyping methods used in epidemiological analyses, 
although both techniques fail to accurately resolve mononucleotide repeats longer than 15 
bp [3-7]. There is also a need for an inexpensive, fast and reliable method for 
differentiating Map isolates, which could be fulfilled by fragment analysis. Fragment 
analysis was conducted on 88 isolates form Newfoundland dairy farms based on SSRs of 
4 loci, and 44 distinct strains were successfully genotyped and differentiated. A 
polyclonal infection pattern was mostly observed between and within farms, and no 
predominant or overrepresented strains were identified. The total number of Map SSR-
types found in animal isolates was higher in dairy herds from Newfoundland, compared 
to farms from other geographical regions in related studies [5,6,8]. Thus, a fragment 
analysis based approach for SSR-typing would be an improved strain typing method 
compared to other molecular methods due to its high resolution capability and 
discriminatory power. Thus, this method can be useful in generating and analyzing large 
quantities of molecular epidemiologic data within a short time frame. In the future, Map 
isolates from dairy herds from other provinces in Atlantic Canada (except Prince Edward 
Island) will be subjected to fragment analysis for comparison to the SSR-types that were 
identified in Newfoundland in the current study.  
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4.3 Conclusion 
Overall goal of this thesis was to genetically type two animal pathogens that cause 
significant financial losses to the dairy industry in NL and other regions of the world. The 
two molecular methods described in this study were easily adaptable and were robust 
enough to differentiate among different isolates of Klebsiella and Map, respectively. 
Results from the described work showed that a single genotype could not be associated 
with large scale infections, suggesting a polyclonal pattern in the circulating isolates for 
each pathogen, based on the techniques used in the current analysis. Thus, in the future 
whole genome sequencing studies should be performed for more in-depth genetic 
analysis of the Map isolates so that the questions regarding co- or multiple- infections 
within/between animal(s) can be clarified, which is important in terms of source tracking 
and the status of the animals involved. Future research will contribute to the significance 
and implications of the described/current findings. 
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Appendix A: Sequence analysis of 4 SSR loci for multiple standards used in 
Map strain determination 
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Figure A.1: Sequence analysis of multiple standards (S1, S2 and S3) based on the 4 SSR 
loci used in the present study. (A-L) Each SSR locus (L) is mentioned in parenthesis, 
S3 (L3): GGT5 
Forward sequencing Reverse sequencing 
S3 (L3): GGT5 
Forward sequencing Reverse sequencing 
S3 (L4): TGC5 
Reverse sequencing 
S3 (L4): TGC5 
Reverse sequencing 
S3 (L4): TGC5 
Reverse sequencing 
K
L
 97 
 
followed by mononucleotide or trinucleotide repeats. Sequencing errors were observed in 
either forward or reverse sequences of S2 and S3 for locus 4, and S3 for locus 2, 
respectively. 
 
 
